Kim R

601 total citations
41 papers, 398 citations indexed

About

Kim R is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Kim R has authored 41 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Kim R's work include Lung Cancer Treatments and Mutations (5 papers), Peptidase Inhibition and Analysis (2 papers) and HIV/AIDS drug development and treatment (2 papers). Kim R is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Peptidase Inhibition and Analysis (2 papers) and HIV/AIDS drug development and treatment (2 papers). Kim R collaborates with scholars based in United States, Japan and Australia. Kim R's co-authors include Pyong Gap Min, Carolyn G. Loh, Annette C. Reboli, John D. Baxter, Masahiko Nishiyama, T Toge, Kosuke Okada, Shuji Saeki, Osvaldo J. López and Kathryn C. Behling and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Academic Medicine.

In The Last Decade

Kim R

39 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim R United States 11 101 95 71 55 55 41 398
Sougat Ray India 11 87 0.9× 28 0.3× 77 1.1× 39 0.7× 65 1.2× 55 568
Melissa Alexander United States 10 48 0.5× 106 1.1× 62 0.9× 67 1.2× 46 0.8× 31 387
Pierre Bataille France 15 139 1.4× 85 0.9× 53 0.7× 13 0.2× 125 2.3× 73 689
Margaret A. Johnson United Kingdom 9 253 2.5× 80 0.8× 194 2.7× 24 0.4× 138 2.5× 19 660
Ruochen Zhang China 11 45 0.4× 45 0.5× 33 0.5× 47 0.9× 32 0.6× 20 310
Klaus König Germany 14 21 0.2× 49 0.5× 84 1.2× 31 0.6× 45 0.8× 65 570
Aimée Julien United States 14 162 1.6× 54 0.6× 28 0.4× 113 2.1× 93 1.7× 21 753
Stephanie Curry United States 14 178 1.8× 15 0.2× 89 1.3× 39 0.7× 251 4.6× 26 545
Paul Wallace United States 9 37 0.4× 27 0.3× 147 2.1× 59 1.1× 50 0.9× 20 645
Mary Ellen Ross United States 13 11 0.1× 108 1.1× 157 2.2× 250 4.5× 61 1.1× 34 1.1k

Countries citing papers authored by Kim R

Since Specialization
Citations

This map shows the geographic impact of Kim R's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim R with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim R more than expected).

Fields of papers citing papers by Kim R

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim R. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim R. The network helps show where Kim R may publish in the future.

Co-authorship network of co-authors of Kim R

This figure shows the co-authorship network connecting the top 25 collaborators of Kim R. A scholar is included among the top collaborators of Kim R based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim R. Kim R is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, Dorothy H., et al.. (2023). A salivary biomarker panel to detect liver cirrhosis. iScience. 26(7). 107015–107015. 3 indexed citations
2.
Loh, Carolyn G., et al.. (2022). Identifying Plan Perceptions: Higher Education Institutions as Arts and Cultural Anchors. Urban Affairs Review. 59(5). 1496–1529. 3 indexed citations
3.
Loh, Carolyn G., et al.. (2022). Placemaking in Practice: Municipal Arts and Cultural Plans’ Approaches to Placemaking and Creative Placemaking. Journal of Planning Education and Research. 44(3). 1679–1690. 5 indexed citations
4.
R, Kim, et al.. (2020). Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR). SHILAP Revista de lepidopterología.
5.
R, Kim, et al.. (2020). Cooper Medical School of Rowan University. Academic Medicine. 95(9S). S309–S312.
6.
Behling, Kathryn C., et al.. (2017). Does team-based learning improve performance in an infectious diseases course in a preclinical curriculum?. International Journal of Medical Education. 8. 39–44. 18 indexed citations
7.
Mitchell, Murray D., et al.. (2017). An Enhanced Shared Decision Making Model to Address Willingness and Ability to Undergo Lung Cancer Screening and Follow-up Treatment in Minority Underserved Populations. Journal of Community Medicine & Health Education. 7(2). 5 indexed citations
8.
R, Kim, et al.. (2013). Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Szep, Zsofia, Kim R, Sarah J. Ratcliffe, & Stephen J. Gluckman. (2013). Tuberculin skin test conversion rate among short-term health care workers returning from Gaborone, Botswana. Travel Medicine and Infectious Disease. 12(4). 396–400. 7 indexed citations
10.
Paquet, Agnès, John D. Baxter, Jodi Weidler, et al.. (2011). Differences in Reversion of Resistance Mutations to Wild-Type under Structured Treatment Interruption and Related Increase in Replication Capacity. PLoS ONE. 6(1). e14638–e14638. 13 indexed citations
11.
R, Kim & John D. Baxter. (2008). Protease Inhibitor Resistance Update: Where Are We Now?. AIDS Patient Care and STDs. 22(4). 267–277. 21 indexed citations
12.
R, Kim, et al.. (2008). Anidulafungin: a drug evaluation of a new echinocandin. Expert Opinion on Pharmacotherapy. 9(13). 2339–2348. 9 indexed citations
13.
Shukla, Dhananjay, et al.. (2003). Management of age-related macular degeneration.. PubMed. 101(8). 471–4, 476. 2 indexed citations
14.
Thaulow, Erik, Roman Casciano, Julian Casciano, et al.. (2001). A pharmacoeconomic evaluation of amlodipine usage in patients undergoing PTCA in the US using results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES).. PubMed. 12(2). 31–5. 2 indexed citations
15.
Yoshida, Kazuhiro, Naoki Nishimoto, Yusuke Kagawa, et al.. (2001). [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].. PubMed. 28(10). 1403–12. 3 indexed citations
16.
Min, Pyong Gap & Kim R. (1999). Struggle for Ethnic Identity: Narratives by Asian American Professionals. Medical Entomology and Zoology. 18 indexed citations
17.
Nishiyama, Masahiko, Shuji Saeki, Kim R, et al.. (1992). A role for plasma membrane potential in doxorubicin--induced cytotoxicity.. PubMed. 12(3). 849–52. 6 indexed citations
18.
Barnett, GO, et al.. (1990). Closing the Loop on Diagnostic Decision Support Systems.. Annual Symposium on Computer Application in Medical Care. 589–593. 4 indexed citations
19.
Barnett, GO, et al.. (1990). DXplain-Important Issues in the Development of a Computer-Based Decision Support System.. PubMed Central. 1013–1013. 2 indexed citations
20.
Nishiyama, Masahiko, Yujiro Kirihara, Takashi Saeki, et al.. (1988). [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].. PubMed. 15(8). 2285–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026